{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:53:08Z","timestamp":1783425188799,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Education and Science Republic of Serbia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejps.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T16:47:04Z","timestamp":1407775624000},"page":"226-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Solid self-emulsifying phospholipid suspension (SSEPS) with diatom as a drug carrier"],"prefix":"10.1016","volume":"63","author":[{"given":"Mladen","family":"Milovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spomenka","family":"Simovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Lo\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Dashevskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Ibri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.07.010_b0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2008.08.046","article-title":"Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS)","volume":"366","author":"Agarwal","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.07.010_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2736(94)90337-9","article-title":"Calcitonin loaded liposomes: stability under acidic conditions and bile salts-induced disruption resulting in calcitonin\u2013phospholipid complex formation","volume":"1193","author":"Arien","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2014.07.010_b0020","unstructured":"CFR, 2011. Code of Federal Regulations. Part 184 \u2013 Direct Food substances affirmed as Generally Recognized as Safe. Subpart B \u2013 Listing of specific substances Affirmed as GRAS, Section 184.1400, 21CFR184.1400, p. 3."},{"key":"10.1016\/j.ejps.2014.07.010_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","article-title":"Lipid \u2013 an emerging platform for oral delivery of drugs with poor bioavailability review article","volume":"73","author":"Chakraborty","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0030","unstructured":"European Pharmacopeia, 2008. 6th ed., European Department for the Quality of Medicines, Strasburg, pp. 1411\u20131412 (Supplement 2008)."},{"key":"10.1016\/j.ejps.2014.07.010_b0035","unstructured":"FDA, 1995. Guidance for Industry: Immediate Release Solid Oral Dosage Forms \u2013 Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing, and In Vivo Bioequivalance Documentation. Center for Drug Evaluation and Research, Rockville, MD."},{"key":"10.1016\/j.ejps.2014.07.010_b0040","unstructured":"FDA, 1997a. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Center for Drug Evaluation and Research, Rockville, MD."},{"key":"10.1016\/j.ejps.2014.07.010_b0045","unstructured":"FDA, 1997b. Guidance for Industry: SUPAC-MR: Modified Release Solid Oral Dosage Forms \u2013 Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing, and In Vivo Bioequivalance Documentation. Center for Drug Evaluation and Research, Rockville, MD."},{"key":"10.1016\/j.ejps.2014.07.010_b0050","series-title":"Physicochemical Principles of Pharmacy","author":"Florence","year":"2006"},{"key":"10.1016\/j.ejps.2014.07.010_b0055","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"Goodman","year":"2001"},{"key":"10.1016\/j.ejps.2014.07.010_b0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tibtech.2008.11.003","article-title":"The glass menagerie: diatoms for novel applications in nanotechnology","volume":"27","author":"Gordon","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2014.07.010_b0065","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","article-title":"Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I","volume":"92","author":"Grzesiak","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.010_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2004.06.021","article-title":"Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening","volume":"283","author":"Gua","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1039\/f29767201525","article-title":"Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers","volume":"72","author":"Israelachvili","year":"1976","journal-title":"J. Chem. Soc. Faraday Trans. II"},{"key":"10.1016\/j.ejps.2014.07.010_b0080","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.addr.2007.09.006","article-title":"Approaches for the development of solid and semi-solid lipid-based formulations","volume":"60","author":"Jannin","year":"2008","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejps.2014.07.010_b0085","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/op900133z","article-title":"Solvent effects on the crystallization and preferential nucleation of carbamazepine anhydrous polymorphs: a molecular recognition perspective","volume":"13","author":"Kelly","year":"2009","journal-title":"Organic Process Res. Develop."},{"key":"10.1016\/j.ejps.2014.07.010_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2006.03.011","article-title":"Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate","volume":"64","author":"Koga","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0095","first-page":"6302","article-title":"Graphene oxide decorated diatom silica particles as a new nano-hybrid: towards smart natural drug microcarriers","volume":"1","author":"Kumeria","year":"2013","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejps.2014.07.010_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0105","series-title":"Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring. Applied Therapeutics","first-page":"1","article-title":"Carbamazepine, valproic acid, phenobarbital, and ethosuximide","author":"Levy","year":"1992"},{"issue":"2","key":"10.1016\/j.ejps.2014.07.010_b0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/PDT-100100540","article-title":"In situ dehydration of CBZ dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine","volume":"5","author":"Li","year":"2000","journal-title":"Pharm. Dev. Tech."},{"key":"10.1016\/j.ejps.2014.07.010_b0115","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/adma.200803778","article-title":"Diatomaceous lessons in nanotechnology and advanced materials","volume":"21","author":"Losic","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejps.2014.07.010_b0120","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1039\/c0cc01305f","article-title":"Surface functionalization of diatoms with dopamine modified iron oxide nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies","volume":"46","author":"Losic","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejps.2014.07.010_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(02)00003-0","article-title":"Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation","volume":"235","author":"Nazzal","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(03)00365-X","article-title":"Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in water submicron emulsion","volume":"263","author":"Nicolaos","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10717540500395007","article-title":"Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone","volume":"13","author":"Potluri","year":"2006","journal-title":"Drug Deliver."},{"key":"10.1016\/j.ejps.2014.07.010_b0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.07.010_b0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.addr.2007.10.010","article-title":"Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies","volume":"60","author":"Pouton","year":"2008","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejps.2014.07.010_b0150","first-page":"1","article-title":"Conventional and alternative methods to improve oral bioavailability of lipophilic drugs","volume":"1","author":"Prajapati","year":"2007","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.010_b0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2011.04.015","article-title":"Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS)","volume":"412","author":"Shanmugam","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2014.07.010_b0160","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/157016311796799026","article-title":"Silica materials in drug delivery applications","volume":"8","author":"Simovic","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"issue":"7","key":"10.1016\/j.ejps.2014.07.010_b0170","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2217\/nnm.11.29","article-title":"Silica microcapsules from diatoms as a new carrier for delivery of therapeutics","volume":"6","author":"Sinn Aw","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2014.07.010_b0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.powtec.2011.04.023","article-title":"Porous silica microshells from diatoms as biocarrier for drug delivery applications","volume":"223","author":"Sinn Aw","year":"2012","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejps.2014.07.010_b0175","series-title":"Perry\u2019s Chemical Engineers\u2019 Handbook","first-page":"8","article-title":"Size reduction and size enlargement","author":"Snow","year":"1997"},{"key":"10.1016\/j.ejps.2014.07.010_b0180","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/jps.21638","article-title":"Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs","volume":"98","author":"Speybroeck","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"40","key":"10.1016\/j.ejps.2014.07.010_b0185","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1002\/anie.200604488","article-title":"Mesoporous materials for drug delivery","volume":"46","author":"Valet-Regi","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2014.07.010_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micromeso.2008.07.002","article-title":"Ordered mesoporous materials for drug delivery","volume":"117","author":"Wang","year":"2009","journal-title":"Micropor. Mesopor. Mat."},{"key":"10.1016\/j.ejps.2014.07.010_b0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcis.2008.10.077","article-title":"Design and optimization of a new self-nanoemulsifying drug delivery system","volume":"330","author":"Wang","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2014.07.010_b0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2009.07.014","article-title":"Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits","volume":"140","author":"Xu","year":"2009","journal-title":"J. Control. Rel."},{"issue":"1","key":"10.1016\/j.ejps.2014.07.010_b0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1081\/PDT-120002234","article-title":"Estimation of initial dissolution rate of drug substance by thermal analysis: application for carbamazepine","volume":"7","author":"Yoshihashi","year":"2002","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2014.07.010_b0210","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1021\/la102083t","article-title":"Synthesis of self-supporting gold microstructures with 3-d morphologies by direct replication of diatom templates","volume":"26","author":"Yu","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2014.07.010_b0215","series-title":"Encyclopedia of Dairy Sciences","author":"Zhou","year":"2011"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:45:14Z","timestamp":1760528714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714003066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":43,"alternative-id":["S0928098714003066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.010","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid self-emulsifying phospholipid suspension (SSEPS) with diatom as a drug carrier","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}